文献速递血液净化与透析

KDQOL-36量表在美国透析患者中的心理测量学特性

Psychometric Properties of the Kidney Disease Quality of Life 36-Item Short-Form Survey (KDQOL-36) in the United States.
PubMed 文献 · Am J Kidney Dis · 2017-11-08

本研究基于2015年6月至2016年5月美国1381家透析机构的70786例透析患者的KDQOL-36问卷数据,评估其信效度。结果显示肾脏病靶向量表内部一致性信度(α=0.83-0.85)和机构水平信度(r=0.75-0.83)可接受,验证了原量表因子结构,构念效度获支持。

要点

  • KDQOL-36肾脏病靶向量表信度可接受(α=0.83-0.85)。
  • 量表因子结构与原设计一致,构念效度获支持。
  • 不同透析类型、糖尿病状态和就业状况患者得分有差异。

核心结论

  • KDQOL-36量表在美国透析患者中具有可接受的内部一致性信度和构念效度。

研究设计与样本

  • 二次数据分析,评估KDQOL-36的信度和因子结构。
  • 样本为70786例美国透析患者,来自1381家允许数据分析的透析机构。
  • 数据收集于2015年6月1日至2016年5月31日,作为常规临床评估的一部分。

主要发现

  • 肾脏病靶向量表内部一致性信度α=0.83-0.85,机构水平信度r=0.75-0.83。
  • 条目-总分相关和验证性因子分析支持原量表因子结构。
  • SF-12躯体成分总结与心理成分总结和KDQOL-36量表得分相关性r=0.40-0.52。
  • 不同透析类型、糖尿病与非糖尿病、全职就业与非全职就业患者间量表得分存在显著差异。

临床怎么用

  • KDQOL-36可用于美国透析患者健康相关生活质量的评估。

局限性

  • 使用临床登记处的二次数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Centers for Medicare & Medicaid Services require that dialysis patients' health-related quality of life be assessed annually. The primary instrument used for this purpose is the Kidney Disease Quality of Life 36-Item Short-Form Survey (KDQOL-36), which includes the SF-12 as its generic core and 3 kidney disease-targeted scales: Burden of Kidney Disease, Symptoms and Problems of Kidney Disease, and Effects of Kidney Disease. Despite its broad use, there has been limited evaluation of KDQOL-36's psychometric properties. STUDY DESIGN: Secondary analyses of data collected by the Medical Education Institute to evaluate the reliability and factor structure of the KDQOL-36 scales. SETTINGS & PARTICIPANTS: KDQOL-36 responses from 70,786 dialysis patients in 1,381 US dialysis facilities that permitted data analysis were collected from June 1, 2015, through May 31, 2016, as part of routine clinical assessment. MEASUREMENTS & OUTCOMES: We assessed the KDQOL-36 scales' internal consistency reliability and dialysis facility-level reliability using coefficient alpha and 1-way analysis of variance. We evaluated the KDQOL-36's factor structure using item-to-total scale correlations and confirmatory factor analysis. Construct validity was examined using correlations between SF-12 and KDQOL-36 scales and "known groups" analyses. RESULTS: Each of the KDQOL-36's kidney disease-targeted scales had acceptable internal consistency reliability (α=0.83-0.85) and facility-level reliability (r=0.75-0.83). Item-scale correlations and a confirmatory factor analysis model evidenced the KDQOL-36's original factor structure. Construct validity was supported by large correlations between the SF-12 Physical Component Summary and Mental Component Summary (r=0.40-0.52) and the KDQOL-36 scale scores, as well as significant differences on the scale scores between patients receiving different types of dialysis, diabetic and nondiabetic patients, and patients who were employed full-time versus not. LIMITATIONS: Use of secondary data from a clinical registry. CONCLUSIONS: The study provides support for the reliability and construct validity of the KDQOL-36 scales for assessment of health-related quality of life among dialysis patients.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Peipert JD, Bentler PM, Klicko K, et al. Psychometric Properties of the Kidney Disease Quality of Life 36-Item Short-Form Survey (KDQOL-36) in the United States. Am J Kidney Dis. 2017. PMID: 29128411. doi:10.1053/j.ajkd.2017.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。